Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade

Victoria Klepsch(Innsbruck Medical University), Gottfried Baier(Innsbruck Medical University)
Nature Communications
April 12, 2018
Cited by 72


Related Papers